{'fraction_non_alphanumeric': 0.017660044150110375, 'fraction_numerical': 0.008830022075055188, 'mean_word_length': 5.579710144927536, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Review: Considerations in Current Treatment of COVID-19 in Patients with Chronic Kidney Disease

Patients with CKD and particularly ESRD or transplantation are at a significantly high risk of mortality from COVID infection [1,2]. Given this high risk of poor outcomes, nephrologists and critical care physicians are more inclined to use available therapies in hospitalized patients without comprehensive insight into risks and safety in this population.